We serve Chemical Name:6-nitroquinazolin-2-amine CAS:882670-94-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-nitroquinazolin-2-amine
CAS.NO:882670-94-2
Synonyms:6-Nitro-2-quinazolinamine
Molecular Formula:C8H6N4O2
Molecular Weight:190.15900
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:473.876ºC at 760 mmHg
Density:1.532g/cm3
Index of Refraction:1.76
PSA:97.62000
Exact Mass:190.04900
LogP:2.22460
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6-Nitro-2-quinazolinamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Nitro-2-quinazolinamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Nitro-2-quinazolinamine Use and application,6-Nitro-2-quinazolinamine technical grade,usp/ep/jp grade.
Related News: When they do design their phase 3, they’re going to need to be better about that part of the study design, and really focus on enrolling individuals that have the right biomarkers to be able to look at not only the safety and tolerability but also the efficacy on cognition and function,” Edelmayer said.
The vaccine approach is promising because using the body’s immune system to fight Alzheimer’s would sidestep one of the problems in developing a drug to treat the disease — namely that it’s difficult to design medications that can easily enter the brain and attack a specific target, Edelmayer explained.
Through booster doses given every three months, the vaccine is “training your body over time how to react to the pathological tau,” Edelmayer said. “You will likely need additional shots of this particular therapeutic to keep it as productive as possible in targeting that tau. 6-nitroquinazolin-2-amine manufacturer Roche too has been riding high on the stock exchange this week, as investors still hope its more extensive Alzheimer’s profile could come good. 6-nitroquinazolin-2-amine supplier Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage. 6-nitroquinazolin-2-amine vendor Roche too has been riding high on the stock exchange this week, as investors still hope its more extensive Alzheimer’s profile could come good. 6-nitroquinazolin-2-amine factory In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining.
The vaccine approach is promising because using the body’s immune system to fight Alzheimer’s would sidestep one of the problems in developing a drug to treat the disease — namely that it’s difficult to design medications that can easily enter the brain and attack a specific target, Edelmayer explained.
Through booster doses given every three months, the vaccine is “training your body over time how to react to the pathological tau,” Edelmayer said. “You will likely need additional shots of this particular therapeutic to keep it as productive as possible in targeting that tau. 6-nitroquinazolin-2-amine manufacturer Roche too has been riding high on the stock exchange this week, as investors still hope its more extensive Alzheimer’s profile could come good. 6-nitroquinazolin-2-amine supplier Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage. 6-nitroquinazolin-2-amine vendor Roche too has been riding high on the stock exchange this week, as investors still hope its more extensive Alzheimer’s profile could come good. 6-nitroquinazolin-2-amine factory In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining.
